Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2012 by Clalit Health Services
Sponsor:
Information provided by (Responsible Party):
Timna Naftali, Clalit Health Services
ClinicalTrials.gov Identifier:
NCT01494857
First received: December 15, 2011
Last updated: October 28, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)